PharmaShots Weekly Snapshots (Mar 15 - 19, 2021)
Published: Mar 19, 2021 | Tags: Takeda, Collaborates, Anima, Discover, Develop, mRNA Translation Modulators, Neurological Diseases
Kiniksa's Arcalyst (rilonacept) Receives the US FDA's Approval for the Treatment of Pericarditis
Published: Mar 19, 2021 | Tags: Kiniksa, Arcalyst (rilonacept), Receives, US, FDA, Approval, Treatment, Pericarditis
Published: Mar 19, 2021 | Tags: Sarepta Therapeutics, Report, Results, SRP-9003, Treatment, Limb-Girdle Muscular Dystrophy Type 2E
Pfizer Signs a WW License Agreement with Pyxis to Develop and Commercialize Two ADC Candidates
Published: Mar 19, 2021 | Tags: Pfizer, Signs, WW, License Agreement, Pyxis, Develop, Commercialize, Two ADC Candidates
Published: Mar 19, 2021 | Tags: Boston, Signs, Out-License, Option Agreement, GSK, Advance, Two Programs, Oncology, CNS Disorders
Published: Mar 19, 2021 | Tags: Gilead, Expands, Collaboration, Novo Nordisk, Evaluate, Triple Combination Regimen, Compensated, Cirrhosis (F4), NASH
GSK Initiates P-III Study of GSK3511294 (GSK'294) for the Treatment of Severe Asthma
Published: Mar 18, 2021 | Tags: GSK, Initiates, P-III, Study, GSK3511294 (GSK-294), Treatment, Severe Asthma
Published: Mar 18, 2021 | Tags: Merck, Keytruda (pembrolizumab), Receives, EC, Approval, Adults & Pediatric patients, R/R cHL
Published: Mar 18, 2021 | Tags: FSD Pharma, Signs, License Agreement, Innovet, Develop, Veterinary Drugs, Gastro-Intestinal, Diseases
Merck Signs a Five-Year Agreement with M2GEN to Advance Cancer Therapies
Published: Mar 18, 2021 | Tags: Merck, Signs, Five-Year, Agreement, M2GEN, Advance, Cancer Therapies
WuXi Biologics to Acquire Pfizer's Biologics Manufacturing Facilities in China
Published: Mar 18, 2021 | Tags: WuXi Biologics, Acquire, Pfizer, Biologics, Manufacturing Facilities, China
Merck Collaborates with Amathus Therapeutics to Develop Treatments for Neurodegenerative Diseases
Published: Mar 18, 2021 | Tags: Merck, Collaborates, Amathus Therapeutics, Develop, Treatments, Neurodegenerative Diseases
NCCN Collaborates with Pfizer for New Biosimilars Research Projects in Oncology
Published: Mar 17, 2021 | Tags: NCCN, Collaborates, Pfizer, New, Biosimilars, Research Projects, Oncology
Published: Mar 17, 2021 | Tags: Johnson & Johnson, Report, Long-Term Data, Tremfya (guselkumab), P-III DISCOVER-2, Study, Active, Psoriatic Arthritis
FibroGen Initiates P-III LELANTOS-2 Study of Pamrevlumab for Duchenne Muscular Dystrophy
Published: Mar 17, 2021 | Tags: FibroGen, Initiates, P-III LELANTOS-2, Study, Pamrevlumab, Duchenne Muscular Dystrophy
Sanofi Out Licenses Two Sickle Cell Disease Programs to GBT for $353M
Published: Mar 17, 2021 | Tags: Sanofi, Out Licenses, Two Sickle Cell Disease Programs, GBT, $353M
Lilly Reports Results of Mirikizumab in P-III LUCENT-1 Induction Study for Ulcerative Colitis
Published: Mar 17, 2021 | Tags: Lilly, Reports, Results, Mirikizumab, P-III LUCENT-1, Induction Study, Ulcerative Colitis
GSK and Medicago Initiate P-III Trial for Adjuvanted COVID-19 Vaccine Candidate
Published: Mar 17, 2021 | Tags: GSK and Medicago, Initiate, P-III Trial, Adjuvanted, COVID-19 Vaccine Candidate
Published: Mar 16, 2021 | Tags: Merck, Reports, US, FDA, Acceptance, NDA, Priority Review, Belzutifan (MK-6482),Treat, Patients, Von Hippel-Lindau Disease Associated RCC
Genentech Reports Two-Year Data of Evrysdi (risdiplam) for People with Type 2 or Type 3 SMA
Published: Mar 16, 2021 | Tags: Genentech, Reports, Two-Year Data, Evrysdi (risdiplam), People, Type 2 or Type 3 SMA
Roche Launches Cobas SARS-CoV-2 Variant Test to Detect Emerging Coronavirus Mutations
Published: Mar 16, 2021 | Tags: Roche, Launches, Cobas SARS-CoV-2 Variant Test, Detect, Emerging, Coronavirus, Mutations
Published: Mar 16, 2021 | Tags: Novartis and Molecular Partners, Report, Inclusion, Ensovibep (MP0420), NIH-Sponsored, ACTIV-3 Trial, Treatment, COVID 19
Gilead Collaborates with Merck to Jointly Develop and Commercialize Lenacapavir + Islatravir for HIV
Published: Mar 16, 2021 | Tags: Gilead, Collaborates, Merck, Jointly, Develop, Commercialize, Lenacapavir, Islatravir, HIV
Published: Mar 16, 2021 | Tags: Takeda, Signs, License Agreement, Genevant, Develop, Novel, Nucleic Acid, Therapeutics, Liver Fibrosis
Published: Mar 15, 2021 | Tags: BioXcel, BXCL501, Receives, US, FDA, Breakthrough Therapy Designation, Acute, Treatment, Agitation, Associated, Dementia
Cardinal Health to Divest its Cordis Business to Hellman & Friedman for $1B
Published: Mar 15, 2021 | Tags: Cardinal Health, Divest, Cordis Business, Hellman & Friedman, $1B
Published: Mar 15, 2021 | Tags: BMS, Collaborates, Aveo, Evaluate, Opdivo (nivolumab), Fotivda (tivozanib), P-III Study, Relapsed Renal Cell Carcinoma
Roche to Acquire GenMark Diagnostics for $1.8B
Published: Mar 15, 2021 | Tags: Roche, Acquire, GenMark Diagnostics, $1.8B
Regeneron and Sanofi Report Results of Libtayo (cemiplimab) in P-III Trial for Cervical Cancer
Published: Mar 15, 2021 | Tags: Regeneron and Sanofi, Report, Results, Libtayo (cemiplimab), P-III Trial, Cervical Cancer
Eli Lilly Report Result of Donanemab in P-II TRAILBLAZER-ALZ Study for Alzheimer's Disease
Published: Mar 15, 2021 | Tags: Eli Lilly, Report, Result, Donanemab, P-II TRAILBLAZER-ALZ, Study, Alzheimer's Disease
Related Post: PharmaShots Weekly Snapshots (Mar 08 - 12, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com